MeridianLink Inc (MLNK) Fundamental Analysis & Valuation

NYSE:MLNKUS58985J1051

Current stock price

20.01 USD
0 (0%)
At close:
20.01 USD
0 (0%)
After Hours:

This MLNK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MLNK Profitability Analysis

1.1 Basic Checks

  • In the past year MLNK was profitable.
  • In the past year MLNK had a positive cash flow from operations.
  • MLNK had negative earnings in 4 of the past 5 years.
  • In the past 5 years MLNK always reported a positive cash flow from operatings.
MLNK Yearly Net Income VS EBIT VS OCF VS FCFMLNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • MLNK has a Return On Assets of -2.40%. This is comparable to the rest of the industry: MLNK outperforms 50.88% of its industry peers.
  • MLNK has a Return On Equity (-5.73%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 1.00%, MLNK is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
  • MLNK had an Average Return On Invested Capital over the past 3 years of 1.67%. This is significantly below the industry average of 10.90%.
Industry RankSector Rank
ROA -2.4%
ROE -5.73%
ROIC 1%
ROA(3y)-2.41%
ROA(5y)-2.58%
ROE(3y)-5.04%
ROE(5y)-5.86%
ROIC(3y)1.67%
ROIC(5y)2.77%
MLNK Yearly ROA, ROE, ROICMLNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • The Operating Margin of MLNK (3.38%) is better than 66.32% of its industry peers.
  • MLNK's Operating Margin has declined in the last couple of years.
  • MLNK has a Gross Margin (66.39%) which is comparable to the rest of the industry.
  • MLNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.38%
PM (TTM) N/A
GM 66.39%
OM growth 3Y-42.83%
OM growth 5Y-27.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.99%
MLNK Yearly Profit, Operating, Gross MarginsMLNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. MLNK Health Analysis

2.1 Basic Checks

  • MLNK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • MLNK has less shares outstanding than it did 1 year ago.
  • MLNK has less shares outstanding than it did 5 years ago.
  • MLNK has a worse debt/assets ratio than last year.
MLNK Yearly Shares OutstandingMLNK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MLNK Yearly Total Debt VS Total AssetsMLNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • MLNK has an Altman-Z score of 1.60. This is a bad value and indicates that MLNK is not financially healthy and even has some risk of bankruptcy.
  • MLNK has a Altman-Z score (1.60) which is in line with its industry peers.
  • MLNK has a debt to FCF ratio of 5.25. This is a neutral value as MLNK would need 5.25 years to pay back of all of its debts.
  • MLNK has a Debt to FCF ratio (5.25) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.18 is on the high side and indicates that MLNK has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.18, MLNK is doing worse than 76.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 5.25
Altman-Z 1.6
ROIC/WACC0.09
WACC11.3%
MLNK Yearly LT Debt VS Equity VS FCFMLNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.01 indicates that MLNK has no problem at all paying its short term obligations.
  • MLNK has a better Current ratio (2.01) than 60.35% of its industry peers.
  • MLNK has a Quick Ratio of 2.01. This indicates that MLNK is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.01, MLNK is doing good in the industry, outperforming 61.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 2.01
MLNK Yearly Current Assets VS Current LiabilitesMLNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. MLNK Growth Analysis

3.1 Past

  • MLNK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 500.00%, which is quite impressive.
  • The Revenue has been growing slightly by 5.96% in the past year.
  • Measured over the past years, MLNK shows a quite strong growth in Revenue. The Revenue has been growing by 15.68% on average per year.
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%225%
Revenue 1Y (TTM)5.96%
Revenue growth 3Y5.72%
Revenue growth 5Y15.68%
Sales Q2Q%7.53%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.86% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MLNK will show a small growth in Revenue. The Revenue will grow by 5.56% on average per year.
EPS Next Y61.5%
EPS Next 2Y40.96%
EPS Next 3Y35.86%
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y5.23%
Revenue Next 3Y5.56%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MLNK Yearly Revenue VS EstimatesMLNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
MLNK Yearly EPS VS EstimatesMLNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

4

4. MLNK Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 55.58 indicates a quite expensive valuation of MLNK.
  • MLNK's Price/Earnings ratio is in line with the industry average.
  • MLNK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.23.
  • A Price/Forward Earnings ratio of 41.96 indicates a quite expensive valuation of MLNK.
  • MLNK's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.42, MLNK is valued quite expensively.
Industry RankSector Rank
PE 55.58
Fwd PE 41.96
MLNK Price Earnings VS Forward Price EarningsMLNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 76.84% of the companies in the same industry are more expensive than MLNK, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, MLNK is valued cheaper than 84.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.65
EV/EBITDA 26.86
MLNK Per share dataMLNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MLNK's earnings are expected to grow with 35.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)N/A
EPS Next 2Y40.96%
EPS Next 3Y35.86%

0

5. MLNK Dividend Analysis

5.1 Amount

  • MLNK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MLNK Fundamentals: All Metrics, Ratios and Statistics

MeridianLink Inc

NYSE:MLNK (10/23/2025, 8:18:22 PM)

After market: 20.01 0 (0%)

20.01

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-29
Earnings (Next)03-04
Inst Owners39.22%
Inst Owner Change-94.18%
Ins Owners4.35%
Ins Owner Change-34.16%
Market Cap1.48B
Revenue(TTM)325.89M
Net Income(TTM)-22.49M
Analysts53.85
Price Target20.36 (1.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.09%
Min EPS beat(2)-23.27%
Max EPS beat(2)27.45%
EPS beat(4)2
Avg EPS beat(4)-6.22%
Min EPS beat(4)-30.14%
Max EPS beat(4)27.45%
EPS beat(8)3
Avg EPS beat(8)-36.84%
EPS beat(12)4
Avg EPS beat(12)0.28%
EPS beat(16)6
Avg EPS beat(16)11.07%
Revenue beat(2)1
Avg Revenue beat(2)0.25%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)1.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)1.58%
Revenue beat(8)1
Avg Revenue beat(8)-0.94%
Revenue beat(12)3
Avg Revenue beat(12)-0.96%
Revenue beat(16)6
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)4.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 55.58
Fwd PE 41.96
P/S 4.54
P/FCF 16.65
P/OCF 15.37
P/B 3.77
P/tB N/A
EV/EBITDA 26.86
EPS(TTM)0.36
EY1.8%
EPS(NY)0.48
Fwd EY2.38%
FCF(TTM)1.2
FCFY6.01%
OCF(TTM)1.3
OCFY6.51%
SpS4.4
BVpS5.31
TBVpS-5.33
PEG (NY)0.9
PEG (5Y)N/A
Graham Number6.56
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -5.73%
ROCE 1.27%
ROIC 1%
ROICexc 1.12%
ROICexgc N/A
OM 3.38%
PM (TTM) N/A
GM 66.39%
FCFM 27.28%
ROA(3y)-2.41%
ROA(5y)-2.58%
ROE(3y)-5.04%
ROE(5y)-5.86%
ROIC(3y)1.67%
ROIC(5y)2.77%
ROICexc(3y)1.8%
ROICexc(5y)2.98%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.11%
ROCE(5y)3.5%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-38.18%
ROICexc growth 5Y-18.44%
OM growth 3Y-42.83%
OM growth 5Y-27.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 5.25
Debt/EBITDA 6.7
Cap/Depr 12.8%
Cap/Sales 2.28%
Interest Coverage 0.31
Cash Conversion 139.43%
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 2.01
Altman-Z 1.6
F-Score6
WACC11.3%
ROIC/WACC0.09
Cap/Depr(3y)15.92%
Cap/Depr(5y)15.49%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%225%
EPS Next Y61.5%
EPS Next 2Y40.96%
EPS Next 3Y35.86%
EPS Next 5YN/A
Revenue 1Y (TTM)5.96%
Revenue growth 3Y5.72%
Revenue growth 5Y15.68%
Sales Q2Q%7.53%
Revenue Next Year5.02%
Revenue Next 2Y5.23%
Revenue Next 3Y5.56%
Revenue Next 5YN/A
EBIT growth 1Y-41.37%
EBIT growth 3Y-39.56%
EBIT growth 5Y-16.36%
EBIT Next Year74.11%
EBIT Next 3Y25.17%
EBIT Next 5YN/A
FCF growth 1Y72.85%
FCF growth 3Y-5.78%
FCF growth 5Y34.88%
OCF growth 1Y57.66%
OCF growth 3Y-4.68%
OCF growth 5Y28.98%

MeridianLink Inc / MLNK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MeridianLink Inc?

ChartMill assigns a fundamental rating of 4 / 10 to MLNK.


What is the valuation status for MLNK stock?

ChartMill assigns a valuation rating of 4 / 10 to MeridianLink Inc (MLNK). This can be considered as Fairly Valued.


Can you provide the profitability details for MeridianLink Inc?

MeridianLink Inc (MLNK) has a profitability rating of 3 / 10.


What is the financial health of MeridianLink Inc (MLNK) stock?

The financial health rating of MeridianLink Inc (MLNK) is 5 / 10.